Back to top
more

Ekso Bionics Holdings, Inc. (EKSO)

(Delayed Data from NSDQ)

$5.02 USD

5.02
137,160

-0.14 (-2.71%)

Updated May 13, 2021 04:00 PM ET

After-Market: $5.00 -0.02 (-0.40%) 7:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 17% (208 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Brokerage Reports

Research for EKSO

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Ekso Bionics Holdings, Inc. [EKSO]

Reports for Purchase

Showing records 1 - 19 ( 19 total )

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 1

05/11/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for EKSO

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 2

02/26/2021

Company Report

Pages: 6

Subscription-Based Service Model Bodes Well for Growth; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 3

10/30/2020

Company Report

Pages: 7

Recovery Continues; EVO Launch Could Add to Growth; Adjusting PT to $11; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 4

07/31/2020

Company Report

Pages: 6

On Track to Recovery; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 5

06/26/2020

Company Report

Pages: 6

Label Expansion Bodes Well for Long-Term Growth; Increased PT to $12; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 6

06/15/2020

Company Report

Pages: 7

Multi-Unit Network Strategy Could Drive Growth; Adjusting PT to $8; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 7

01/10/2020

Daily Note

Pages: 3

Pre-announced Record 4Q19 Bodes Well For Continued Growth in 2020; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 8

10/31/2019

Company Report

Pages: 7

Growth Momentum Continues Delivering Strongest 3Q; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 9

10/28/2019

Company Report

Pages: 24

We are initiating coverage with Buy rating and a 12-month price target of $1.20 per share

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 75.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 10

07/14/2017

Company Report

Pages: 8

We are dropping coverage to better allocate resources within our coverage universe.

Provider: H.C. Wainwright & Co., Inc.

Price: 25.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 11

07/29/2016

Company Report

Pages: 4

Ramping Sales and Marketing; 2Q16 Results Update

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 12

04/04/2016

Daily Note

Pages: 3

FDA Clearance Recieved; Maintain Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 13

03/15/2016

Company Report

Pages: 4

4Q15 Quarterly Results Update; Era Under New Leadership Begins

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 14

02/26/2016

Daily Note

Pages: 3

New Leadership to Focus on Commercial Expansion; Maintain Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 15

11/09/2015

Company Report

Pages: 5

Industrial Segment Commercialization and 510(k) Clearance Are Near-Term Catalysts; Maintain Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 16

08/13/2015

Company Report

Pages: 4

Healthy 2Q15 Results; Contribution from Industrial Suits May Happen Faster; Maintain Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 17

07/08/2015

Company Report

Pages: 3

New York Sales Demo Reinforces Positive Outlook

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 18

06/03/2015

Daily Note

Pages: 3

Unnecessary Volatility Created By Anonymous Article; Maintaining Buy Rating

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Ekso Bionics Holdings, Inc.

Industry: Medical - Instruments

Record: 19

05/12/2015

Company Report

Pages: 31

Commercializing the Next Generation of Human Augmentation Systems; Initiating Coverage with a Buy

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: DAYAL A

Price: 75.00

Research Provided by a Third Party